Core Scientific, Inc. Form 8-K Summary
Report date: March 12, 2024. The filing announces the release of financial results for the fourth fiscal quarter and full year ended December 31, 2023.
Business Context and Reporting Period
Core Scientific, Inc. is a Delaware company whose common stock and warrants trade on Nasdaq. The filing reports results for the quarter and year ended December 31, 2023, under Items 2.02 and 7.01.
Financial Metrics
The filing text provided does not include the underlying revenue, profit or loss, cash flow, margin, debt, liquidity, operating, or other financial metrics. Those details were furnished in Exhibit 99.1, the March 12, 2024 press release, and Exhibit 99.2, the company presentation, but the exhibit contents are not included in the provided text.
Material Changes Versus Prior Period
The filing text does not provide a clear comparison with the prior comparable quarter or year.
Guidance, Outlook, Risks, and Unusual Items
No guidance, outlook, management commentary, risk updates, contingencies, or unusual items are described in the provided filing text. The filing states that the information furnished under Items 2.02 and 7.01, including the exhibits, is not deemed filed for purposes of Section 18 of the Exchange Act and is not incorporated by reference into other filings.
Key Facts for Investor Verification
- Review Exhibit 99.1 for the reported fourth-quarter and full-year 2023 financial results.
- Review Exhibit 99.2 for management’s presentation, operating metrics, commentary, and any outlook.
- Verify revenue, profitability, cash flow, debt, liquidity, mining and hosting metrics, and period-over-period changes directly against the exhibits.
- Note that the financial information was furnished rather than filed under Section 18 of the Exchange Act.